292 related articles for article (PubMed ID: 16411146)
41. Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.
Akaishi J; Sugino K; Kameyama K; Masaki C; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Shimizu K; Ito K
World J Surg; 2015 Jul; 39(7):1728-35. PubMed ID: 25743484
[TBL] [Abstract][Full Text] [Related]
42. Hurthle cell neoplasm of the thyroid gland.
Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
[TBL] [Abstract][Full Text] [Related]
43. Outcome in papillary carcinoma of the thyroid.
Franssila KO
Ann Chir Gynaecol; 1978; 67(2):49-57. PubMed ID: 677774
[TBL] [Abstract][Full Text] [Related]
44. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma.
Koo JS; Shin E; Hong SW
APMIS; 2010 Oct; 118(10):744-52. PubMed ID: 20854468
[TBL] [Abstract][Full Text] [Related]
46. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
47. The histopathology analysis of the diffuse sclerosing variant of the papillary carcinoma of the thyroid: a distinctive and rare form.
Vrabie CD; Terzea D; Petrescu A; Waller M
Rom J Morphol Embryol; 2009; 50(4):743-8. PubMed ID: 19942977
[TBL] [Abstract][Full Text] [Related]
48. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.
Kebebew E; Treseler PA; Ituarte PH; Clark OH
World J Surg; 2001 May; 25(5):632-7. PubMed ID: 11369991
[TBL] [Abstract][Full Text] [Related]
49. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
[TBL] [Abstract][Full Text] [Related]
50. [Papillary thyroid carcinoma: clinical manifestations, recurrences and prognosis].
Hay ID
Vestn Khir Im I I Grek; 2006; 165(1):43-5. PubMed ID: 16568855
[TBL] [Abstract][Full Text] [Related]
51. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
52. Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma.
Kim JM; Kim TY; Kim WB; Gong G; Kim SC; Hong SJ; Shong YK
Laryngoscope; 2006 Nov; 116(11):2081-5. PubMed ID: 17075398
[TBL] [Abstract][Full Text] [Related]
53. Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics.
Okada T; Sasaki F; Takahashi H; Taguchi K; Takahashi M; Watanabe K; Itoh T; Ota S; Todo S
Eur J Pediatr Surg; 2006 Feb; 16(1):8-13. PubMed ID: 16544219
[TBL] [Abstract][Full Text] [Related]
54. [Clinical analysis of young adult thyroid papillary cancer patients with bilateral cervical metastases].
Zhang L; Guo Z; Wang YL; Ji QH
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):467-9. PubMed ID: 17686304
[TBL] [Abstract][Full Text] [Related]
55. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
56. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
57. Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas.
Lin JD; Chao TC; Hsueh C
Clin Endocrinol (Oxf); 2007 Feb; 66(2):224-8. PubMed ID: 17223992
[TBL] [Abstract][Full Text] [Related]
58. Recurrent papillary thyroid cancer: analysis of prognostic factors including the histological variant.
Ortiz S; Rodríguez JM; Parrilla P; Pérez D; Moreno-Gallego A; Rios A; Soria T
Eur J Surg; 2001 Jun; 167(6):406-12. PubMed ID: 11471663
[TBL] [Abstract][Full Text] [Related]
59. Central neck dissection for papillary thyroid cancer.
Rosenbaum MA; McHenry CR
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1092-7. PubMed ID: 19917920
[TBL] [Abstract][Full Text] [Related]
60. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
